Swiss Startup Atlas Bio Raises $12.5M to Simulate Drug Trials
Atlas Bio, founded in 2024, trains an AI model on human RNA data to run virtual trials. Creandum led the round.
Latest articles
US CEO Exits Drop 40% in September; Women Take 27.9% of New Posts
Challenger, Gray & Christmas counted 111 CEO changes in September, the lowest month of 2026. Women make up 27.9% of new CEOs so far this year.
Imperial College Spinout Machenta Lands $40M Seed Round
The London robotics startup has 11 employees. It trains its model only in simulated environments and aims to teach robots a task from one demonstration.
Vistry Names Severn Trent's Helen Miles as Its New CFO
Vistry Group has appointed Severn Trent finance chief Helen Miles as CFO, due to join in 2027, and put former Crown Estate CFO Robert Allen in the role on an interim basis.
P&G's New CEO Bets on Premium Diapers to Defend Prices
Procter & Gamble posted its best organic sales growth in 11 quarters. CEO Shailesh Jejurikar is pairing cheaper pack sizes with pricier new products such as Amore diapers.
Lette Raises $6.5M Seed Round for UK Rental AI
Lette, which builds AI software for residential property operators, closed a $6.5 million seed round led by Peak and plans to enter more European markets in 2027.